The Latvian cardiac drug that rewired Soviet athletics — and caught 99 athletes in a single month. A carnitine inhibitor that forces your cells to burn glucose instead of fat, producing more energy per oxygen molecule under hypoxic stress.
Meldonium is a structural analogue of γ-butyrobetaine (GBB) — the natural precursor to L-carnitine. By mimicking GBB, it blocks the final enzyme in carnitine biosynthesis and forces a fundamental shift in cellular energy metabolism.
Why this matters under stress: During intense exercise, cardiac ischemia, or high-altitude conditions, oxygen delivery lags demand. Switching to glucose oxidation means the same amount of oxygen produces more ATP — potentially the difference between cardiac function and failure, or sustained performance and collapse.
Meldonium has an unusually robust clinical trial base for an Eastern European pharmaceutical, with approvals in over 10 countries and evidence across cardiovascular, cerebrovascular, and neurological indications.
When WADA added meldonium to its banned list on January 1, 2016, it triggered the largest single-drug doping scandal in sports history. The drug had been openly used by Eastern European athletes for decades — treating it as nothing more than a standard cardiovascular supplement.
Clinical dosing from Eastern European prescribing guidelines. These are not medical recommendations — meldonium is not approved for use in the US, EU, UK, Canada, or Australia.
Cycling rationale: Continuous use is not recommended because the body adapts by upregulating carnitine synthesis over time and efficacy diminishes. Periodic depletion/recovery cycles maintain the metabolic effect. Long-term continuous use in animal models has shown gut microbiome disruption.
Legal status: WADA Banned (S4) Rx — Eastern Europe Not FDA Approved Research Chemical (US)
Clinical safety data from Eastern European trials is generally favorable at therapeutic doses. Long-term safety in healthy users (non-cardiac populations) is not well-characterized.
Drug Interactions: L-Carnitine supplementation directly competes with meldonium for OCTN2 transport, accelerating elimination and reducing meldonium's effect — relevant both for washout strategies and assessing whether carnitine co-supplementation is useful. Combining with nitrates or antihypertensives may potentiate hypotensive effects due to additive NO/vasodilatory action.
Contraindications: Severe renal impairment (primarily renally cleared). Pregnancy and lactation (insufficient data). Hypersensitivity to the compound.
Meldonium's legal status reflects its unusual position — approved medicine in some countries, banned doping substance in sport worldwide, and unregulated gray-market compound elsewhere.
| Country / Region | Status | Notes |
|---|---|---|
| Latvia | Approved (OTC) | Home of Grindeks, the manufacturer. Fully approved, available over-the-counter. |
| Russia | Approved (Rx) | Widely prescribed cardiovascular drug. Prescription required but broadly available. |
| Ukraine, Belarus, Kazakhstan, Georgia + CIS | Approved | Approved in most post-Soviet states as standard cardiovascular therapy. |
| United States | Not FDA Approved | Not scheduled/controlled. Not available through licensed US pharmacies. Available via gray-market suppliers. |
| European Union (exc. Latvia) | Not EMA Approved | No EU-wide approval. Not in EU formularies. Available through gray-market channels in some countries. |
| United Kingdom, Canada, Australia | Not Licensed | Not approved by regulatory authorities. Personal import rules vary. |
| WADA / All Sports | Banned (S4) | Prohibited in-competition AND out-of-competition. No established TUE pathway. 100 ng/mL reporting threshold. |
Honest assessment of the evidence base — because distinguishing established science from speculation matters.
Primary research behind the data on this page. Click PMID links to read full papers on PubMed.
Relevant products for meldonium protocols and mitochondrial support. Affiliate links help support MeetPeptide at no extra cost to you.
Amazon affiliate links — we earn a small commission at no extra cost to you. Product recommendations are based on relevance to this topic, not paid placement.
Other compounds in the nootropic, metabolic, and Soviet-era performance research space.